Amarin Corporation plc
AMRN
Rank in Stocks
#15811
Amarin Corporation plc is a pharmaceutical firm dedicated to the research,... Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's flagship product is VASCEPA, an omega-3 fatty acid formulation available by prescription only. This medication acts as an adjunctive therapy to diet, designed to decrease elevated triglyceride levels in adult patients suffering from severe hypertriglyceridemia. Amarin primarily distributes its offerings through wholesale channels and specialized pharmacy providers. Furthermore, the company has entered into a collaboration with Mochida Pharmaceutical Co., Ltd. to advance the development and market introduction of drug products and new indications derived from Vascepa's active pharmaceutical ingredient, which encompasses omega-3 acid and eicosapentaenoic acid. Established in 1989 as Ethical Holdings plc, the organization rebranded to Amarin Corporation plc in 1999. Its corporate headquarters are located in Dublin, Ireland.
Share Price
$11.74
Last synced: 2026-11-09
Market Cap
$242.82M
Change (1 day)
1.12%
Change (1 year)
-27.04%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Amarin Corporation plc (AMRN)
Category
Healthcare
Operating Margin for Amarin Corporation plc (AMRN)
Operating Margin as of November 2026 TTM: -13.97%
According to Amarin Corporation plc's latest financial reports, its current operating margin (TTM) is -13.97%. At the end of 2025 the company had an operating margin of -6.53%.
Operating Margin history for Amarin Corporation plc from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -13.97% | 113.94% |
| 2025 | -6.53% | -83.74% |
| 2024 | -40.15% | 82.33% |
| 2023 | -22.02% | -23.22% |
| 2022 | -28.68% | -1,693.33% |
| 2021 | 1.80% | -156.25% |
| 2020 | -3.20% | -43.36% |
| 2019 | -5.65% | -88.03% |
| 2018 | -47.22% | 87.75% |
| 2017 | -25.15% | -50.15% |
| 2016 | -50.45% | -58.01% |
| 2015 | -120.14% | -32.14% |
| 2014 | -177.03% | -74.38% |
| 2013 | -691.08% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | -100.00% |
| 2007 | -433.46% | -93.04% |
| 2006 | -6,232.20% | 64.80% |
| 2005 | -3,781.60% | 246.73% |
| 2004 | -1,090.66% | 106.92% |
| 2003 | -527.10% | 957.16% |
| 2002 | -49.86% | -50.97% |
| 2001 | -101.70% | 505.00% |
| 2000 | -16.81% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -102.76% |
US
|
|
| -149.01% | -89.33% |
US
|
|
| 25.57% | -101.83% |
AU
|
|
| 31.23% | -102.24% |
BE
|
|
| 29.35% | -102.10% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Amarin Corporation plc's operating margin
What is Amarin Corporation plc's operating margin?
Amarin Corporation plc's operating margin is -13.97%, as of Nov 2026.
What was Amarin Corporation plc's operating margin in 2025?
In 2025, Amarin Corporation plc's operating margin was -6.53%, compared with -40.15% in 2024.
How has Amarin Corporation plc's operating margin changed since 2020?
From 2020 to 2025, Amarin Corporation plc's operating margin was highest in 2021 (1.80%) and lowest in 2024 (-40.15%).
How does Amarin Corporation plc's operating margin compare with similar companies?
Amarin Corporation plc's operating margin (-13.97%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.